The Benefits of Glass BCTs
When developing critical assays, such as liquid biopsy-based cancer tests and pre-natal genetic screening kits, the composition of blood collection tu…
Read More Nanotrap® Extraction Advanced Technology (NEAT) Liquid Biopsy – Streck BCT
The NEAT Liquid Biopsy Kit– Streck BCT is formulated to capture, concentrate and extract cfDNA from plasma samples isolated from Streck blood collection tubes. It is optimized for automated and manual workflows.
For Research Use Only. Not for use in diagnostic procedures.
Product Description
The NEAT Liquid Biopsy Kit – Streck BCT uses Nanotrap hydrogel particles to specifically bind and capture smaller cfDNA fragments from plasma collected into Streck blood collection tubes. This means purer, higher concentrations of cfDNA for use in downstream qPCR, dPCR, ddPCR and/or sequencing assays.
Find the peace of mind that comes with enhanced cfDNA yields.
Features
- Nanotrap hydrogel particle technology
- Optimized for use with Cell-Free DNA BCT® and Nucleic Acid BCT™
- Compatible with qPCR, dPCR, ddpCR and sequencing assays
Benefits
- Captures 97% of cfDNA (50-250 base pairs) in base matrix
- Better detection of mutant alleles
- Established automated and manual isolation methods for 1-4 ml plasma samples
Compatibility and Efficacy of Ceres NEAT Liquid Biopsy Kit – Streck BCT with Blood Collected in Streck Cell-Free DNA BCT
Ordering Information
| Description | Catalog Number |
|---|---|
| Nanotrap Extraction Advanced Technology (NEAT) Liquid Biopsy – Streck BCT | 250082 |
Order NEAT
Liquid Biopsy Kit – Streck BCT today
New customers
Existing customers
International customers find a distributor
Resources
Instructions IFU
Certificates
SDS
Product Information
Protocols
NEAT Liquid Biopsy Kit User Guide – Kit Contents and Equipment Lists
Looking for an older document? Click here for archived assays and certificates.
Stabilization Products
With our patented portfolio of stabilization solutions, you can ship and store samples at room temperature, mitigating pre-analytical variation in critical samples, easing handling concerns and allowing for batch processing.
The latest from the blog
Stabilization
Stabilization
FDA clearance brings liquid biopsy into a new era
With the FDA clearance of several assays, liquid biopsy moves closer toward the goal of making this screening method a standard of care. Liquid biopsy…
Read More 
Stabilization
How can nucleic acids predict disease?
Liquid biopsy is a diagnostic technique where bodily fluids are examined for biomarkers that suggest disease. In recent years, liquid biopsy has been …
Read More 